The LINC Management Team
The founding LINC team include members with strong
backgrounds and considerable experience and demonstrated
expertise in science, medicine, and business.
Kenneth W Narducy, PhD, MBA. LINC corporate co-founder.
Dr Narducy is a veteran with over 25 years in the biomedical
industry. He has worked in big pharma (Abbott Labs, Schering-
Plough) and raw startups (Oculex Pharmaceuticals and Centaur
Pharmaceuticals). He has managed R&D organizations including
research, product development, regulatory affairs, and clinical
development. Oculex, an ophthalmic drug delivery company that
he helped found, was purchased by Allergan in late 2003 for
$230 million. Dr Narducy earned his BA at Wartburg College,
Waverly, IA, his PhD at Ohio State University, Columbus, OH,
and his MBA from the University of Chicago.
J Michael Delmage, PhD, MBA. LINC corporate co-founder.
Dr Delmage has been a pharmaceutical/biotechnology expert and
executive for more than 25 years. He has been a key manager in
companies involved in the development and commercialization of
cutting-edge biotechnology products (Chiron, Celtrix),
therapeutic drugs (Santen, Senetek), and medical devices (SBH).
He was also a co-founder of Oculex, an ophthalmic drug
delivery company that was purchased by Allergan in late 2003
for $230 million. Dr Delmage holds a BS in Biological Sciences
from California State University at Long Beach, a PhD in
Cellular and Molecular Biology from the University of Southern
California, and an MBA from Pepperdine University.
John S Torday, PhD. Scientific founder and Scientific Advisory
Board chairman. Dr Torday is Professor of Pediatrics and
Obstatrics/Gynecology Director of the Perinatal Biology
Program, and Director of the Harry L Guenther Laboratory for
Cell Molecular Biology at the Harbor-UCLA Medical Center,
Torrance, CA. He has been in lung research for over 25 years,
with particular interest in fetal lung development, pulmonary
surfactant biochemistry, pulmonary fibrosis, and chronic lung
disease. Dr Torday received his BA from Boston University and
his Masters of Science and PhD from McGill University. Before
joining Harbor-UCLA in 1998, Dr. Torday held academic
appointments at Harvard Medical School (1976-1991) and the
University of Maryland School of Medicine (1991-1998).
Virender K Rehan, MD, FAAP. Scientific co-founder and
Medical Affairs Advisor. Dr Rehan is Assistant Professor in the
Department of Pediatrics, Director of Neonatal Intensive Care,
and Associate Director of the Neonatal Fellowship Program at
the Harbor-UCLA Medical Center, Torrance, CA. He is Board
Certified in Neonatal-Perinatal Medicine and in Pediatrics.
Dr Rehan received his MBBS and MD from Delhi University
College of Medical Sciences. He continued his training in Saudi
Arabia, Liverpool, Dublin, London, Edinburgh, and Canada
before joining the faculty at the Brown University School of
Medicine in Rhode Island in 1995. He joined Harbor-UCLA
in 2000.
|
